Liberia vs Mexico: The number of people with susceptibility test result for rifampicin
Liberia
37.16
in 2021
Mexico
35.3
in 2021
Liberia rank
126th
Mexico rank
128th
The number of people with susceptibility test result for rifampicin over time
- Liberia
- Mexico
How they compare
Liberia currently reports 37.16 against 35.3 in Mexico, a difference of 1.86.
That makes Liberia's figure about 1.1 times Mexico's.
Across all 5 years both countries report, Liberia has been ahead every year.
Liberia ranks 126th and Mexico ranks 128th of 146 countries.
Liberia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liberia | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 35.42 | 1.27 | 34.14 | Liberia |
| 2020s | 30.78 | 29.51 | 1.27 | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Liberia or Mexico?
- Liberia, at 37.16 against 35.3 in Mexico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Liberia and Mexico?
- 1.86, with Liberia ahead.
- How many years of comparable data are there for Liberia and Mexico?
- 5 years are reported by both, from 2017 to 2021.
- How do Liberia and Mexico rank globally for the number of people with susceptibility test result for rifampicin?
- Liberia ranks 126th and Mexico ranks 128th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.